use within 34 weeks Research Information Type: Growth hormone fragment Pathways: Lipolysis Focus: Fat metabolism Scientific Information Research Reference Parameters Laboratory Use Only Initial phase: 0.3 mg once daily, 5 days on / 2 days off Standard research range: 0.50 mg once daily, 5 days on / 2 days off Advanced research range: 1.0 mg once daily, 5 days on / 2 days off Research cycles typically range from 812 weeks Mechanism of Action AOD-9604 works by mimicking the lipolytic region of growth hormone
Conversely, if a patient presents with pernicious anemia or severe neurological signssuch as intense tingling in the hands, memory loss, or muscle weaknessthe dosage remains the same (usually 1,000 mcg), but the frequency increases significantly
A sore, red, or swollen tongue (glossitis)
Never discontinue prescribed B12 treatment without medical advice, as untreated deficiency can lead to serious complications
Side Effects: The information below is a partial list of side effects